{"id":"https://openalex.org/W2992010214","doi":null,"title":"[Evaluation of Bevacizumab in Combination with Weekly Paclitaxel for Locally Advanced Breast Cancer].","display_name":"[Evaluation of Bevacizumab in Combination with Weekly Paclitaxel for Locally Advanced Breast Cancer].","publication_year":2016,"publication_date":"2016-11-01","ids":{"openalex":"https://openalex.org/W2992010214","mag":"2992010214","pmid":"https://pubmed.ncbi.nlm.nih.gov/28133011"},"language":"ja","primary_location":{"id":"pmid:28133011","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28133011","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109452985","display_name":"Hitoshi Sugimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153859","display_name":"Soka Municipal Hospital","ror":"https://ror.org/0540c8n94","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210153859"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hitoshi Sugimoto","raw_affiliation_strings":["Dept. of Surgery, Soka Municipal Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Surgery, Soka Municipal Hospital","institution_ids":["https://openalex.org/I4210153859"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019400143","display_name":"Fukuichiro Orita","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fukuichiro Orita","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Yuichiro Kume","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuichiro Kume","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102408499","display_name":"Hironobu Baba","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hironobu Baba","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102019294","display_name":"Yuya Sato","orcid":"https://orcid.org/0000-0003-1657-4749","observed_orcids":["https://orcid.org/0000-0003-1657-4749"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuya Sato","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113734511","display_name":"Naoaki Hoshino","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naoaki Hoshino","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5044943701","display_name":"Yoshinobu Nishioka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshinobu Nishioka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"43","issue":"12","first_page":"1424","last_page":"1426"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0052999998442828655,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11885","display_name":"MRI in cancer diagnosis","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9900000095367432},{"id":"https://openalex.org/keywords/weekly-paclitaxel","display_name":"weekly paclitaxel","score":0.9990000128746033},{"id":"https://openalex.org/keywords/locally-advanced-breast-cancer","display_name":"locally advanced breast cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6850000023841858},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.7139999866485596},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.531000018119812},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7580000162124634},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9919999837875366},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.765999972820282},{"id":"https://openalex.org/keywords/luminal-breast-cancer","display_name":"luminal breast cancer","score":0.8870000243186951}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9088122248649597},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7280307412147522},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6928343772888184},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6159765720367432},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.5664825439453125},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5579238533973694},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.5470952391624451},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.5138488411903381},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5046018362045288},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.5012686252593994},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.48303350806236267},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46754470467567444},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43670931458473206},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.4275176227092743},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3285568058490753},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:28133011","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28133011","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"Journal Article"},{"id":"mag:2992010214","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28133011","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2404815741","https://openalex.org/W2020724013","https://openalex.org/W2398845667","https://openalex.org/W2466735761","https://openalex.org/W4319057928","https://openalex.org/W1964756575","https://openalex.org/W3044385821","https://openalex.org/W2040764007","https://openalex.org/W2005680272","https://openalex.org/W2511182903"],"abstract_inverted_index":{"Locally":[0],"advanced":[1,43,208],"breast":[2,44,209],"cancer":[3,45],"that":[4],"exhibits":[5],"bleeding,":[6],"has":[7,26],"a":[8,27,125,131,137,168],"foul":[9],"odor,":[10],"and":[11,67,82,101,140,152,172,185],"expresses":[12],"an":[13],"exudate":[14],"often":[15],"reduces":[16],"the":[17,186,203],"quality":[18],"of":[19,41,202],"life(QOL).":[20],"Bevacizumab(Bv)in":[21],"combination":[22,37,162,195],"with":[23,148,155,163,196],"weekly":[24,164,197],"paclitaxel(PTX)therapy":[25],"high":[28,169],"response":[29,170],"rate.":[30],"To":[31],"date,":[32],"we":[33],"have":[34,190],"used":[35],"this":[36],"for":[38,206],"8":[39],"cases":[40,115,129,135,147,154],"locally":[42,207],"in":[46,60,64,69,79,85,93,98,104,194],"our":[47],"hospital.":[48],"The":[49,56,72,88,107],"patients'":[50],"mean":[51,108],"age":[52],"was":[53,75,90,111],"62.1":[54],"years.":[55],"tumors":[57],"were":[58,159,175],"T4b":[59],"6":[61],"cases,":[62,95,100],"T4c":[63],"1":[65,70,80,141],"case":[66,81,123,142],"T4d":[68],"case.":[71],"clinical":[73],"stage":[74],"Stage":[76,83],"III":[77],"B":[78,97],"IV":[84],"7":[86],"cases.":[87,106],"subtype":[89],"Luminal":[91,96],"A":[92],"2":[94,105,134,157],"4":[99,128,153],"triple":[102],"negative":[103],"dosage":[109],"duration":[110],"5.8":[112],"months.":[113],"Five":[114],"underwent":[116],"local":[117],"control":[118],"operations":[119],"after":[120,183],"chemotherapy.":[121],"One":[122],"showed":[124],"complete":[126],"response,":[127,133],"had":[130,136,143,167],"partial":[132],"stable":[138],"disease":[139],"progressive":[144],"disease.":[145],"Four":[146],"Grade":[149,156],"2-3":[150],"hypertension":[151],"neutropenia":[158],"identified.":[160],"Bvin":[161],"PTX":[165,198],"therapy":[166,199],"rate,":[171],"5":[173],"patients":[174],"able":[176],"to":[177],"undergo":[178],"surgery.":[179],"As":[180],"QOL":[181],"improved":[182],"treatment":[184],"safety":[187],"did":[188],"not":[189],"any":[191],"problem,":[192],"Bv":[193],"is":[200],"one":[201],"effective":[204],"treatments":[205],"cancer.":[210]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2019-12-13T00:00:00"}